Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells
- PMID: 6328039
- PMCID: PMC254418
- DOI: 10.1128/JVI.51.1.199-207.1984
Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells
Abstract
Epstein-Barr virus (EBV), isolated from P3HR-1 cells, induces early antigen and viral capsid antigen upon infection of human B-lymphoblasts. The strong early antigen- and viral capsid antigen-inducing activity is only observed in P3HR-1 virus preparations harboring particles with defective genomes, suggesting that this biological activity is directly associated with the defective DNA population. After infection of EBV genome-carrying Raji or EBV genome-negative BJAB cells, defective genomes of P3HR-1 EBV DNA are replicated in excess, depending on the multiplicity of infecting EBV particles. Hybridization of the DNA from such infected cells with 32P-labeled EBV DNA after HindIII cleavage reveals six hypermolar fragments. Mapping of these fragments shows that they form one defective genome unit containing four nonadjacent regions (alpha, beta, gamma, and delta) of the nondefective P3HR-1 EBV DNA. Two of the segments (alpha and beta) contain ca. 17 and 13 megadaltons, respectively, from the terminal regions of the P3HR-1 genome, whereas the two smaller segments (gamma and delta) contain ca. 3.7 and 3.0 megadaltons, respectively, originating from the central portion of the genome. In the defective molecule, the regions gamma and delta are present in the opposite orientation compared with nondefective P3HR-1 EBV DNA. Tandem concatemers are formed by fusion of the alpha and beta regions. Our model suggests that tandem concatemers of three defective genome units can be packaged into virions in P3HR-1 cells.
Similar articles
-
Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.Virology. 1984 Aug;137(1):9-19. doi: 10.1016/0042-6822(84)90003-5. Virology. 1984. PMID: 6089423
-
Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.J Virol. 1987 Jun;61(6):1985-91. doi: 10.1128/JVI.61.6.1985-1991.1987. J Virol. 1987. PMID: 3033325 Free PMC article.
-
Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.J Virol. 1986 May;58(2):475-86. doi: 10.1128/JVI.58.2.475-486.1986. J Virol. 1986. PMID: 3009861 Free PMC article.
-
Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.J Virol. 1980 Sep;35(3):603-18. doi: 10.1128/JVI.35.3.603-618.1980. J Virol. 1980. PMID: 6252328 Free PMC article.
-
Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.Int J Cancer. 1980 Sep 15;26(3):357-63. doi: 10.1002/ijc.2910260316. Int J Cancer. 1980. PMID: 6270006
Cited by
-
The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.J Virol. 1994 Dec;68(12):7918-26. doi: 10.1128/JVI.68.12.7918-7926.1994. J Virol. 1994. PMID: 7966582 Free PMC article.
-
Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.J Virol. 1989 Apr;63(4):1721-8. doi: 10.1128/JVI.63.4.1721-1728.1989. J Virol. 1989. PMID: 2538652 Free PMC article.
-
Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis.J Virol. 1991 Dec;65(12):7073-7. doi: 10.1128/JVI.65.12.7073-7077.1991. J Virol. 1991. PMID: 1658397 Free PMC article.
-
Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.Proc Natl Acad Sci U S A. 1988 Dec;85(24):9801-5. doi: 10.1073/pnas.85.24.9801. Proc Natl Acad Sci U S A. 1988. PMID: 2849118 Free PMC article.
-
De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.J Virol. 2007 Sep;81(17):9279-91. doi: 10.1128/JVI.00982-07. Epub 2007 Jun 27. J Virol. 2007. PMID: 17596302 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources